|
IA* |
IA* |
No or <50% myometrial invasion
(superficial) |
|
IB* |
IB* |
≥50% myometrial invasion (deep) |
|
Stage II*: Tumour invades cervical stroma, but does not extend
beyond the uterus |
Stage II*: Tumour invades cervical stroma,
but does not extend beyond the uterus |
Stage II*: Tumour
invades cervical stroma, but does not extend beyond the uterus |
Advanced EC
|
Stage III*: Local and/or regional spread of the tumour
|
Stage III*: Local and/or regional spread of the tumour
|
Stage III*: Local and/or regional spread of the tumour
|
|
IIIA* |
IIIA* |
Tumour invades the serosa of the uterus and/or
adnexae |
|
IIIB* |
IIIB* |
Vaginal and/or parametrial involvement |
|
IIIC* |
IIIC* |
Metastases to pelvic and/or para-aortic lymph
nodes |
|
|
IIIC1* |
Positive pelvic nodes |
|
|
IIIC2* |
Positive para-aortic lymph nodes with/without positive
pelvic lymph nodes |
|
Stage IV*: Tumour invades bladder and/or bowel mucosa, and/or
distant metastases |
Stage IV*: Tumour invades bladder and/or
bowel mucosa, and/or distant metastases |
Stage IV*: Tumour
invades bladder and/or bowel mucosa, and/or distant metastases |
|
IVA* |
IVA* |
Tumour invasion of bladder and/or bowel
mucosa |
|
IVB* |
IVB* |
Distant metastases, including intra-abdominal metastases
and/or inguinal lymph nodes |